Krystal Biotech, Inc. NASDAQ:KRYS

Founder-led company

Krystal Biotech stock price today

$143.96
-15.32
-9.62%
Financial Health
0
1
2
3
4
5
6
7
8
9

Krystal Biotech stock price monthly change

-21.58%
month

Krystal Biotech stock price quarterly change

-21.58%
quarter

Krystal Biotech stock price yearly change

+24.16%
year

Krystal Biotech key metrics

Market Cap
4.59B
Enterprise value
1.97B
P/E
-15.18
EV/Sales
N/A
EV/EBITDA
-15.14
Price/Sales
N/A
Price/Book
4.08
PEG ratio
0.20
EPS
1.96
Revenue
N/A
EBITDA
-38.43M
Income
57.16M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Krystal Biotech stock price history

Krystal Biotech stock forecast

Krystal Biotech financial statements

Krystal Biotech, Inc. (NASDAQ:KRYS): Profit margin
Jun 2023 0 -33.21M
Sep 2023 8.55M 80.74M 943.75%
Dec 2023 42.14M 8.69M 20.63%
Mar 2024 45.25M 932K 2.06%
Krystal Biotech, Inc. (NASDAQ:KRYS): Analyst Estimates
Sep 2025 116.01M 33.89M 29.22%
Oct 2025 133.39M 47.15M 35.35%
Dec 2025 125.03M 37.49M 29.99%
Mar 2026 97.95M 14.74M 15.05%
  • Analysts Price target

  • Financials & Ratios estimates

Krystal Biotech, Inc. (NASDAQ:KRYS): Debt to assets
Jun 2023 684026000 30.91M 4.52%
Sep 2023 790350000 34.40M 4.35%
Dec 2023 818355000 39.71M 4.85%
Mar 2024 853296000 54.05M 6.33%
Krystal Biotech, Inc. (NASDAQ:KRYS): Cash Flow
Jun 2023 -34.19M -15.95M 185.26M
Sep 2023 -21.22M 105.19M 13.38M
Dec 2023 -7.23M -10.16M 2.61M
Mar 2024 15.88M -25.98M 10.58M

Krystal Biotech alternative data

Krystal Biotech, Inc. (NASDAQ:KRYS): Employee count
Aug 2023 210
Sep 2023 210
Oct 2023 210
Nov 2023 210
Dec 2023 210
Jan 2024 210
Feb 2024 210
Apr 2024 229
May 2024 229
Jun 2024 229
Jul 2024 229

Krystal Biotech other data

42.59% -38.98%
of KRYS is owned by hedge funds
10.85M -10.04M
shares is hold by hedge funds

Krystal Biotech, Inc. (NASDAQ:KRYS): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 2500
Feb 2024 0 12200
Mar 2024 0 100000
May 2024 0 20000
Jun 2024 0 100000
Sep 2024 0 100000
Dec 2024 0 100000
Transaction Date Insider Security Shares Price per share Total value Source
Sale
KRISHNAN KRISH S director, 10 perc.. Common Stock 727 $170.43 $123,903
Sale
KRISHNAN KRISH S director, 10 perc.. Common Stock 620 $171.63 $106,408
Sale
KRISHNAN SUMA director, 10 perc.. Common Stock 6,302 $163.07 $1,027,661
Sale
KRISHNAN SUMA director, 10 perc.. Common Stock 8,381 $163.91 $1,373,755
Sale
KRISHNAN SUMA director, 10 perc.. Common Stock 4,909 $164.93 $809,646
Sale
KRISHNAN SUMA director, 10 perc.. Common Stock 5,942 $163.04 $968,807
Sale
KRISHNAN KRISH S director, 10 perc.. Common Stock 8,381 $163.91 $1,373,755
Sale
KRISHNAN SUMA director, 10 perc.. Common Stock 1,977 $165.82 $327,834
Sale
KRISHNAN SUMA director, 10 perc.. Common Stock 923 $166.93 $154,074
Sale
KRISHNAN SUMA director, 10 perc.. Common Stock 911 $169.65 $154,549
Patent
Application
Filling date: 17 Nov 2021 Issue date: 1 Sep 2022
Application
Filling date: 25 Sep 2019 Issue date: 23 Dec 2021
Application
Filling date: 23 Jun 2021 Issue date: 14 Oct 2021
Application
Filling date: 28 Jun 2019 Issue date: 26 Aug 2021
Application
Filling date: 18 Dec 2020 Issue date: 24 Jun 2021
Application
Filling date: 6 Nov 2020 Issue date: 25 Mar 2021
Application
Filling date: 29 Jun 2020 Issue date: 18 Feb 2021
Grant
Filling date: 7 Feb 2020 Issue date: 10 Nov 2020
Grant
Filling date: 26 Apr 2019 Issue date: 29 Sep 2020
Application
Filling date: 7 Feb 2020 Issue date: 13 Aug 2020
Friday, 13 December 2024
zacks.com
Monday, 9 December 2024
globenewswire.com
Wednesday, 4 December 2024
zacks.com
Wednesday, 27 November 2024
globenewswire.com
Wednesday, 6 November 2024
globenewswire.com
Tuesday, 5 November 2024
zacks.com
Monday, 4 November 2024
seekingalpha.com
zacks.com
Monday, 28 October 2024
zacks.com
globenewswire.com
Friday, 18 October 2024
zacks.com
Monday, 14 October 2024
seekingalpha.com
Friday, 13 September 2024
globenewswire.com
Friday, 6 September 2024
globenewswire.com
Tuesday, 3 September 2024
zacks.com
Friday, 30 August 2024
zacks.com
Friday, 9 August 2024
seekingalpha.com
Thursday, 8 August 2024
zacks.com
zacks.com
Wednesday, 7 August 2024
zacks.com
Monday, 5 August 2024
zacks.com
Tuesday, 30 July 2024
seekingalpha.com
Monday, 29 July 2024
zacks.com
Friday, 26 July 2024
globenewswire.com
Thursday, 18 July 2024
zacks.com
Thursday, 23 May 2024
zacks.com
zacks.com
Wednesday, 15 May 2024
seekingalpha.com
GlobeNewsWire
Monday, 6 May 2024
Zacks Investment Research
  • What's the price of Krystal Biotech stock today?

    One share of Krystal Biotech stock can currently be purchased for approximately $143.96.

  • When is Krystal Biotech's next earnings date?

    Unfortunately, Krystal Biotech's (KRYS) next earnings date is currently unknown.

  • Does Krystal Biotech pay dividends?

    No, Krystal Biotech does not pay dividends.

  • How much money does Krystal Biotech make?

    Krystal Biotech has a market capitalization of 4.59B.

  • What is Krystal Biotech's stock symbol?

    Krystal Biotech, Inc. is traded on the NASDAQ under the ticker symbol "KRYS".

  • What is Krystal Biotech's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Krystal Biotech?

    Shares of Krystal Biotech can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Krystal Biotech's key executives?

    Krystal Biotech's management team includes the following people:

    • Mr. Krish S. Krishnan Chairman, Pres & Chief Executive Officer(age: 60, pay: $752,370)
    • Ms. Suma M. Krishnan Founder, Chief Operating Officer & Director(age: 60, pay: $532,270)
    • Ms. Kathryn A. Romano Chief Accounting Officer(age: 44, pay: $200,870)
  • Is Krystal Biotech founder-led company?

    Yes, Krystal Biotech is a company led by its founder Ms. Suma M. Krishnan.

  • How many employees does Krystal Biotech have?

    As Jul 2024, Krystal Biotech employs 229 workers.

  • When Krystal Biotech went public?

    Krystal Biotech, Inc. is publicly traded company for more then 7 years since IPO on 20 Sep 2017.

  • What is Krystal Biotech's official website?

    The official website for Krystal Biotech is krystalbio.com.

  • Where are Krystal Biotech's headquarters?

    Krystal Biotech is headquartered at 2100 Wharton Street, Pittsburgh, PA.

  • How can i contact Krystal Biotech?

    Krystal Biotech's mailing address is 2100 Wharton Street, Pittsburgh, PA and company can be reached via phone at +41 25865830.

Krystal Biotech company profile:

Krystal Biotech, Inc.

krystalbio.com
Exchange:

NASDAQ

Full time employees:

229

Industry:

Biotechnology

Sector:

Healthcare

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.

2100 Wharton Street
Pittsburgh, PA 15203

CIK: 0001711279
ISIN: US5011471027
CUSIP: 501147102